• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Safe use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center.

作者信息

Pothen Lucie, Yildiz Halil, De Greef Julien, Penaloza Andrea, Beauloye Christophe, Belkhir Leila, Yombi Jean Cyr

机构信息

Department of Internal Medicine and Infectious Diseases, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.

Department of Internal Medicine and Infectious Diseases, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.

出版信息

Travel Med Infect Dis. 2020 Jul-Aug;36:101788. doi: 10.1016/j.tmaid.2020.101788. Epub 2020 Jun 12.

DOI:10.1016/j.tmaid.2020.101788
PMID:32540396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7290202/
Abstract
摘要

相似文献

1
Safe use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center.在新型冠状病毒肺炎疫情背景下羟氯喹及其与阿奇霉素联合使用的安全性：比利时一家三级中心的临床经验
Travel Med Infect Dis. 2020 Jul-Aug;36:101788. doi: 10.1016/j.tmaid.2020.101788. Epub 2020 Jun 12.
2
Hydroxychloroquine-azithromycin for COVID-19 - Warranted or dangerous?用于治疗COVID-19的羟氯喹啉-阿奇霉素——合理还是危险？
Travel Med Infect Dis. 2020 May-Jun;35:101764. doi: 10.1016/j.tmaid.2020.101764. Epub 2020 May 30.
3
No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".没有证据表明用羟氯喹和阿奇霉素对新冠病毒疾病患者进行早期治疗有临床益处：对《用羟氯喹和阿奇霉素对新冠病毒疾病患者进行早期治疗：法国马赛1061例回顾性分析》的评论
Travel Med Infect Dis. 2020 Jul-Aug;36:101819. doi: 10.1016/j.tmaid.2020.101819. Epub 2020 Jul 3.
4
Hydroxychloroquine and azithromycin as a treatment of COVID-19.羟氯喹和阿奇霉素作为新型冠状病毒肺炎的一种治疗方法。
Intern Emerg Med. 2020 Aug;15(5):841-843. doi: 10.1007/s11739-020-02388-y. Epub 2020 May 30.
5
Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".关于羟氯喹和阿奇霉素作为新冠病毒病早期治疗药物疗效的相互矛盾的证据。对“法国马赛1061例新冠病毒病患者早期使用羟氯喹和阿奇霉素治疗的回顾性分析”的评论
Travel Med Infect Dis. 2020 Sep-Oct;37:101861. doi: 10.1016/j.tmaid.2020.101861. Epub 2020 Sep 1.
6
Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend.新冠病毒肺炎患者短期使用羟氯喹和阿奇霉素的经验及其对QTc趋势的影响
J Infect. 2020 Aug;81(2):e117-e119. doi: 10.1016/j.jinf.2020.05.058. Epub 2020 May 28.
7
Update Alert: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians.最新警报：临床医生应单独使用氯喹或羟氯喹，还是与阿奇霉素联合使用来预防或治疗新型冠状病毒肺炎？美国医师协会的实践要点
Ann Intern Med. 2020 Jul 21;173(2):W48-W51. doi: 10.7326/M20-3862. Epub 2020 Jun 17.
8
Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going.阿奇霉素与 SARS-CoV-2 感染：我们现在在哪里，以及我们将走向何方。
J Glob Antimicrob Resist. 2020 Sep;22:680-684. doi: 10.1016/j.jgar.2020.06.016. Epub 2020 Jul 1.
9
Update Alert 2: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians.最新警报2：临床医生应单独使用氯喹或羟氯喹，还是与阿奇霉素联合使用来预防或治疗新型冠状病毒肺炎？美国医师协会的临床实践要点
Ann Intern Med. 2020 Sep 1;173(5):W88-W89. doi: 10.7326/L20-1007. Epub 2020 Jul 30.
10
Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19.羟氯喹啉联合阿奇霉素对一组新发COVID-19老年患者体内SARS-CoV-2清除的明显无效性。
Travel Med Infect Dis. 2020 Sep-Oct;37:101826. doi: 10.1016/j.tmaid.2020.101826. Epub 2020 Jul 31.

引用本文的文献

1
Efficacy of chloroquine and hydroxychloroquine for the treatment of hospitalized COVID-19 patients: a meta-analysis.氯喹和羟氯喹治疗住院COVID-19患者的疗效：一项荟萃分析。
Future Virol. 2021 Nov. doi: 10.2217/fvl-2021-0119. Epub 2021 Dec 3.
2
QTc prolongation in COVID-19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta-analysis.在接受羟氯喹、氯喹、阿奇霉素或洛匹那韦/利托那韦治疗的 COVID-19 患者中出现 QTc 延长：系统评价和荟萃分析。
Pharmacoepidemiol Drug Saf. 2021 Jun;30(6):694-706. doi: 10.1002/pds.5234. Epub 2021 Apr 3.
3
Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset decades of clinical practice?新冠疫情后时代的羟氯喹：这场大流行会颠覆数十年的临床实践吗？
Clin Rheumatol. 2021 Apr;40(4):1649-1657. doi: 10.1007/s10067-020-05572-9. Epub 2021 Jan 15.
4
Rationale for azithromycin in COVID-19: an overview of existing evidence.COVID-19 中使用阿奇霉素的理由：现有证据概述。
BMJ Open Respir Res. 2021 Jan;8(1). doi: 10.1136/bmjresp-2020-000806.
5
Clinical characteristics and short-term prognosis of in-patients with diabetes and COVID-19: A retrospective study from an academic center in Belgium.糖尿病合并 COVID-19 患者的临床特征和短期预后：来自比利时某学术中心的回顾性研究。
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):149-157. doi: 10.1016/j.dsx.2020.12.020. Epub 2020 Dec 14.
6
The New Coronavirus (SARS-CoV-2): A Comprehensive Review on Immunity and the Application of Bioinformatics and Molecular Modeling to the Discovery of Potential Anti-SARS-CoV-2 Agents.新型冠状病毒（SARS-CoV-2）：免疫综述及生物信息学和分子建模在发现潜在抗 SARS-CoV-2 药物中的应用。
Molecules. 2020 Sep 7;25(18):4086. doi: 10.3390/molecules25184086.
7
The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19).血红素加氧酶 1（HMOX1）通路作为 2019 年新型冠状病毒（COVID-19，即 SARS-CoV-2）治疗和预防的有前途靶点。
Int J Mol Sci. 2020 Sep 3;21(17):6412. doi: 10.3390/ijms21176412.

本文引用的文献

1
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.羟氯喹和阿奇霉素联合治疗 COVID-19 患者：法国马赛 1061 例回顾性分析。
Travel Med Infect Dis. 2020 May-Jun;35:101738. doi: 10.1016/j.tmaid.2020.101738. Epub 2020 May 5.
2
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study.羟氯喹和阿奇霉素联合治疗至少随访 6 天的 80 例 COVID-19 患者的临床和微生物学效果：一项前瞻性观察研究。
Travel Med Infect Dis. 2020 Mar-Apr;34:101663. doi: 10.1016/j.tmaid.2020.101663. Epub 2020 Apr 11.
3
Chloroquine and hydroxychloroquine in covid-19.氯喹和羟氯喹在2019冠状病毒病中的应用
BMJ. 2020 Apr 8;369:m1432. doi: 10.1136/bmj.m1432.
4
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).羟氯喹治疗严重急性呼吸综合征冠状病毒 2 （SARS-CoV-2）的体外抗病毒活性和优化剂量设计预测。
Clin Infect Dis. 2020 Jul 28;71(15):732-739. doi: 10.1093/cid/ciaa237.
5
Electrocardiogram abnormalities related to anti-malarials in systemic lupus erythematosus.与系统性红斑狼疮中抗疟药物相关的心电图异常。
Clin Exp Rheumatol. 2018 Jul-Aug;36(4):545-551. Epub 2018 Apr 13.